health ๐ฌ New Ebola Vaccine Candidate in Congo Race
A fifth experimental Ebola vaccine candidate is advancing toward human trials for the Congo outbreak. Minapharm Group, based in Egypt, is set to receive up to $16.5 million from CEPI. This vaccine targets Bundibugyo Ebola, which has seen 5,713 confirmed cases and 2,744 deaths since May. CEPI aims to get at least two candidates authorized for the current and future epidemics. Initial Phase 1 trials will assess safety and immune response before moving to efficacy studies. ๐ฌ